Diazyme Laboratories Inc - Product Pipeline Analysis, 2018 Update

Summary

Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, point of care, DZ lite instrument, analyzer parameters, data sheets. Diazyme Laboratories offers anemia markers, cancer markers, cardiovascular markers, coagulation markers, diabetic markers, electrolyte markers, inflammatory markers, liver markers, renal and pancreatic marker, sepsis marker and vitamin marker. The company’s technology comprise enzyme cycling technology, latex enhanced immunoassay and enzyme-immunoassay. Diazyme Laboratories is headquartered in Poway, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Diazyme Laboratories Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Diazyme Laboratories Inc Company Overview
Diazyme Laboratories Inc Company Snapshot
Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
Diazyme Laboratories Inc – Pipeline Analysis Overview
Diazyme Laboratories Inc - Key Facts
Diazyme Laboratories Inc - Major Products and Services
Diazyme Laboratories Inc Pipeline Products by Development Stage
Diazyme Laboratories Inc Pipeline Products Overview
B7-H4 Assay
B7-H4 Assay Product Overview
DcR3 (DD-C248) Assay
DcR3 (DD-C248) Assay Product Overview
MIC-1 (DD-X065) Assay
MIC-1 (DD-X065) Assay Product Overview
ProADM Point-of-Care
ProADM Point-of-Care Product Overview
ProADM Test
ProADM Test Product Overview
ProANP Test
ProANP Test Product Overview
ProET1 Test
ProET1 Test Product Overview
Spondin-2 (DD-P108) Assay
Spondin-2 (DD-P108) Assay Product Overview
TRAIL-R2 Assay
TRAIL-R2 Assay Product Overview
Diazyme Laboratories Inc - Key Competitors
Diazyme Laboratories Inc - Key Employees
Diazyme Laboratories Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Diazyme Laboratories Inc, Recent Developments
Jul 16, 2018: Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories
Jan 25, 2018: Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association
Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers
Jun 21, 2017: Beckman Coulter Diagnostics Expands Chemistry Menu to Include FDA-cleared Procalcitonin
Nov 28, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Direct HbA1c (Enzymatic, On-Board Lysis) Assay for Clinical Chemistry Analyzers
Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Folate Assay for Clinical Chemistry Analyzers
Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin B12 Assay for Clinical Chemistry Analyzers
Jul 22, 2016: Get Reliable Results with the Diazyme 25-OH Vitamin D Assay for Clinical Chemistry Analyzers
May 23, 2016: Diadexus and Sonic Healthcare USA Sign National Agreement for PLAC Activity Test
Nov 10, 2015: Diadexus Presents New PLAC Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
Diazyme Laboratories Inc Pipeline Products by Equipment Type
Diazyme Laboratories Inc Pipeline Products by Indication
Diazyme Laboratories Inc, Key Facts
Diazyme Laboratories Inc, Major Products and Services
Diazyme Laboratories Inc Number of Pipeline Products by Development Stage
Diazyme Laboratories Inc Pipeline Products Summary by Development Stage
B7-H4 Assay - Product Status
B7-H4 Assay - Product Description
DcR3 (DD-C248) Assay - Product Status
DcR3 (DD-C248) Assay - Product Description
MIC-1 (DD-X065) Assay - Product Status
MIC-1 (DD-X065) Assay - Product Description
ProADM Point-of-Care - Product Status
ProADM Point-of-Care - Product Description
ProADM Test - Product Status
ProADM Test - Product Description
ProANP Test - Product Status
ProANP Test - Product Description
ProET1 Test - Product Status
ProET1 Test - Product Description
Spondin-2 (DD-P108) Assay - Product Status
Spondin-2 (DD-P108) Assay - Product Description
TRAIL-R2 Assay - Product Status
TRAIL-R2 Assay - Product Description
Diazyme Laboratories Inc, Key Employees
Diazyme Laboratories Inc, Subsidiaries
Glossary
List of Figures
Diazyme Laboratories Inc Pipeline Products by Equipment Type
Diazyme Laboratories Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook